Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 18/20 | 0.53 |
| ▸ | BCL2 | P10415 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7975831 | 1.00 | MCL1 (0.53) | MCL1BCL2ALDH1A1LMNAMAPT | |
| SCHEMBL6847018 | 1.00 | MCL1 (0.53) | MCL1BCL2ALDH1A1LMNAMAPT | |
| SCHEMBL4313540 | 1.00 | MCL1 (0.53) | MCL1BCL2ALDH1A1LMNAMAPT | |
| SCHEMBL7975833 | 1.00 | MCL1 (0.53) | MCL1BCL2ALDH1A1LMNAMAPT | |
| SCHEMBL4313544 | 1.00 | MCL1 (0.53) | MCL1BCL2ALDH1A1LMNAMAPT | |
| SCHEMBL8999703 | 0.89 | MCL1 (0.52) | MCL1BCL2ALDH1A1LMNAMAPT | |
| SCHEMBL8999696 | 0.89 | MCL1 (0.52) | MCL1BCL2ALDH1A1LMNAMAPT | |
| SCHEMBL28845988 | 0.88 | MCL1 (0.44) | MCL1BCL2ALDH1A1LMNAMAPT | |
| SCHEMBL28845990 | 0.88 | MCL1 (0.44) | MCL1BCL2ALDH1A1LMNAMAPT | |
| SCHEMBL28845991 | 0.88 | MCL1 (0.44) | MCL1BCL2ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6770741-B1 | USEFUL IN TREATING CONDITIONS AND DISEASES OF A MAMMAL AND HUMAN IN WHICH AN EXCESS OF BRADYKININ OR RELATED KININS ARE PRODUCED OR INJECTED SUCH AS BY INSECT BITES | SCIOS INC. | 2004-08-03 | — | — | US | disclosed |
| EP-0618810-B1 | BRADYKININ ANTAGONIST PEPTIDES | SCIOS NOVA INC (US) | 2001-07-04 | — | — | EP | disclosed |
| US-5385889-A | Substitution of L-proline at the 7-position of the peptide hormone with a D-configuration hydroxyproline ether or thioether converts agonist into antagonist | SCIOS NOVA INC. (US) | 1995-01-31 | — | — | US | disclosed |
| WO-1992018156-A1 | BRADYKININ ANTAGONIST PEPTIDES | NOVA TECHNOLOGY LIMITED PARTNERSHIP (US) | 1992-10-29 | — | — | WO | disclosed |